Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024 2025
Months
January February March April July May June August September October November December
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Students selected for prestigious Stanford Sophomore College
2012-04-04

 

From the left are: Elri Marais, Palesa Mafisa, Prof. Jonathan Jansen, Vice-Chancellor and Rector of the UFS, Goodwill Shelile and Foster Lubbe. Gabriela Schroder and Saeed Abdullah were absent when the photo was taken.
Photo: Hannes Pieterse
4 April 2012


As part of the University of the Free State’s (UFS) comprehensive suite of student leadership development programmes, a strategic partnership with Stanford University, USA has been forged.

Starting in 2012, selected cohorts of high-potential second-year students will annually participate in the Stanford Sophomore College Programme. The UFS and Oxford University in the UK are the only non-Stanford participants in this strategic and unique opportunity.

Following a highly competitive selection process based on both written and oral assessment, managed by the UFS Centre for Teaching and Learning and the Office of the Vice-Chancellor, the first group of six students was recently selected and will visit Stanford University from 1 – 14 September 2012.

The exclusive and high profile Sophomore College has been offered at the prestigious Stanford University on the West Coast of the US for a number of years. It takes the form of a residential summer programme for second-year students who participate and engage in intense academic exploration with peers and professors on a variety of innovative, multidisciplinary topics.

Depending on the course selected, students participate in a variety of intellectual and academic programmes, do research, work in labs, engage in readings of texts and develop presentation skills.

Some courses are held in part or entirely off campus. Advisory sessions to assist students in their preparation, academic orientation and intellectual development will be conducted prior to their departure to add value to the experience at Stanford.

The students will benefit from the programme in many ways, among others the intense academic exploration of topics with an eminent international scholar, immersion in and exploration of a field of interest, the opportunity to hone critical habits of mind, train to become a more engaged and entrepreneurial learners and collaborate and form relationships with friends and peers.
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept